dostarlimab
gsk
[]
a really exciting early-phase clinical trial; success in 12/12 patients. looking forward to results from the larger phase 3 trial. this shows the huge value of the foundational discovery research in labs around the world into the mechanisms of mismatch-repair.
#asco22 
Biochemist. Research Programme Manager for Cancer Research UK. Building diverse and impactful discovery science & biotech communities. ProEU. Opinions mine.